Amedeo Smart

Free Medical Literature Service



Peptic Ulcer

  Free Subscription


4 Aliment Pharmacol Ther
1 BMC Gastroenterol
3 Helicobacter

    Aliment Pharmacol Ther

    Editorial: refractory reflux sensitivity-A place for baclofen? Authors' reply.
    Aliment Pharmacol Ther. 2022;56:725-726.
    >> Share

  2. KATZ PO
    Editorial: refractory reflux sensitivity - a place for baclofen?
    Aliment Pharmacol Ther. 2022;56:723-724.
    >> Share

  3. ANG D
    Letter: a promising Helicobacter pylori regimen-vonoprazan-based therapy. Author's reply.
    Aliment Pharmacol Ther. 2022;56:754-755.
    >> Share

  4. HU Y, Lu NH
    Letter: a promising Helicobacter pylori regimen - vonoprazan-based therapy.
    Aliment Pharmacol Ther. 2022;56:752-753.
    >> Share

    BMC Gastroenterol

  5. WANG R, Wang Q
    Comparison of risk scoring systems for upper gastrointestinal bleeding in patients after renal transplantation: a retrospective observational study in Hunan, China.
    BMC Gastroenterol. 2022;22:353.
    >> Share


  6. MUNIR M, LeMaitre B, Lobo Z, Psevdos G, et al
    A 15-year review of Helicobacter pylori screening and treatment among United States Veterans.
    Helicobacter. 2022 Jul 28:e12919. doi: 10.1111/hel.12919.
    >> Share

  7. MOMMERSTEEG MC, Yu BT, van den Bosch TPP, von der Thusen JH, et al
    Constitutive programmed death ligand 1 expression protects gastric G-cells from Helicobacter pylori-induced inflammation.
    Helicobacter. 2022 Jul 28:e12917. doi: 10.1111/hel.12917.
    >> Share

  8. GAO W, Teng G, Wang C, Xu Y, et al
    Eradication rate and safety of a "simplified rescue therapy": 14-day vonoprazan and amoxicillin dual regimen as rescue therapy on treatment of Helicobacter pylori infection previously failed in eradication: A real-world, retrospective clinical study i
    Helicobacter. 2022 Jul 25:e12918. doi: 10.1111/hel.12918.
    >> Share

Free Medical Abstracts
Privacy Policy

© Amedeo 1997-2016